Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractBACKGROUND: The utility of typing single nucleotide polymorphisms (SNPs) for the determination of the N-acetyltransferase 2 (NAT2) acetylation status is a matter of debate. AIMS OF THE STUDY: Evaluation of the concordance between deduced genotype results of seven human NAT2 SNPs generated by Real-time PCR analysis and human NAT2 phenotypes. METHODS: NAT2 phenotypes of 38 Caucasian workers were determined using a suitable caffeine test method. Genomic DNA aliquots were used for the determination of seven human NAT2-specific SNPs (G191A, C282T, T341C, C481T, G590A, A803G, G857A). RESULTS AND CONCLUSIONS: Phenotypic results based on the molar ratio of 5-acetylamino-6-formylamino-3-methyluracil (AFMU)/(AFMU+1-methlyuric acid (1U)+1-methylxanthine (1X)) calculated from excreted caffeine metabolite levels in urine samples with 0.3 as a cut-off point between slow (<0.3) and rapid acetylators (>or=0.3). Twenty-seven samples belonged to the slow (mean 0.13; range: 0.03-0.25), 11 to the rapid (mean: 0.41; range: 0.34-0.48) acetylators. LightCycler analyses revealed 11 different NAT2 variant combinations, whereby *5B/*5B and *5B/*6A or *5A/*6C (each 21%), were the most frequent. The deduced acetylation status of the seven NAT2 SNPs matched perfectly with the 38 results determined by phenotyping. This study showed a 100% concordance between NAT2 phenotypes and the deduced NAT2 genotypes and the suitability of the high-speed NAT2-specific LightCycler analysis in a Caucasian population.
CitationClin. Chim. Acta 2007, 376 (1-2):240-243
SponsorsThis work was supported by the Hauptverband der Berufsgenossenschaften (BGFA project Mol-D) and the Berufsgenossenschaft Bau, Oberhausen, Germany. A.J. and A.S. are partners of ECNIS (European Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence (NoE) operating with the European Union 6th Framework Program, Priority 5: “Food Quality and Safety" (Contract No. 513943).
- Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
- Authors: Bolt HM, Selinski S, Dannappel D, Blaszkewicz M, Golka K
- Issue date: 2005 Apr
- Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
- Authors: Vincent-Viry M, Pontes ZB, Gueguen R, Galteau MM, Siest G
- Issue date: 1994
- N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
- Authors: Djordjevic N, Carrillo JA, Ueda N, Gervasini G, Fukasawa T, Suda A, Jankovic S, Aklillu E
- Issue date: 2011 Jul
- [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
- Authors: Lu JF, Yi T, Cao XM, Zhuo HT, Ling SS
- Issue date: 1997 Nov
- [The acetylator polymorphism in a Khmer population: clinical consequences].
- Authors: Bechtel YC, Bechtel PR, Lelouët H, Choisy H, Dy NR
- Issue date: 2001 Jul-Aug